medicines verification system will be funded by fees paid by marketing
authorisation (MA) holders whose product data will be held in the national
repository. IMVO’s running costs will be also funded by MA holder fees, with a
contribution from subscriptions paid by IMVO’s member organisations.
MA holders, wholesalers and pharmacies have to pay the costs
of their own internal changes, including changing packaging, installing
scanners, upgrading software systems, etc.